No mice in the NSG.Tg(Hu-IL-15) cohort receiving LV/hu-IL-12 transduced sarcoma met stopping criteria for tumor size; mice who met stopping criteria were for weight loss (n = 2) or post blood draw mortality (n = 1). Here, IL15 is linked to sarcoma.